P. Skowronek, J. Gawron´ski / Tetrahedron: Asymmetry 10 (1999) 4585–4590
4589
4.3.2. N-Phthaloyl-L-valine methyl ester 1e
Yield 89%; oil; [α]D −69.3, c=1, MeOH (lit. [α]D −66.7, c=1.2, MeOH19); 1H NMR δ 0.9 (d, J=6.8
Hz, 3H), 1.15 (d, J=6.7 Hz, 3H), 2.76 (m, 1H), 3.7 (s, 3H), 4.5 (d, J=8.4 Hz, 1H), 7.7–7.9 (m, 4H.); IR
(film) 2963, 1769, 1714, 1467, 1383, 1354, 1332, 1073, 719 cm−1
.
4.3.3. N-Phthaloyl-L-leucine methyl ester 1f
Yield 95%; oil; [α]D −30.2, c=1, MeOH (lit. [α]D −20.8, c=5.6, CHCl320); 1H NMR δ 0.93 (d, J=6.4
Hz, 3H), 0.96 (d, J=5.9 Hz, 3H), 1.5 (m, 1H), 1.96 (ddd, J=4.4, 10, 14.1 Hz, 1H), 2.3 (ddd, J=4.1, 11.6,
14.2 Hz, 1H), 3.37 (s, 3H), 5.0 (dd, J=4.4, 11.5 Hz, 1H), 7.7–7.9 (m, 4H); IR (film) 2958, 2872, 1776,
1746, 1715, 1387, 1255, 720, 530 cm−1
.
4.3.4. N-Phthaloyl-L-cysteine methyl ester 1g
Obtained by treatment of N-phthaloyl-L-cysteine with excess diazomethane in methanol solution, oil;
[α]D −105.5, c=1, CHCl3; 1H NMR δ 2.11 (s, 3H), 3.35 (d, J=7.6 Hz, 2H), 3.77 (s, 3H), 5.04 (t, J=8.0
Hz, 1H), 7.82 (m, 4H); IR (film) 1770, 1715, 1385, 1245, 1100, 715 cm−1
.
4.3.5. (S)-N-Phthaloyl-α-amino-γ-butyrolactone 2a
N-Carboethoxyphthalimide (87 mg, 0.4 mmol) was dissolved in DMF (1 ml) and α-amino-γ-
butyrolactone hydrochloride (55 mg, 0.4 mmol) and Et3N (40 mg, 0.4 mmol) were added. The mixture
was stirred for 4 h at room temperature. Half of the solvent was evaporated in vacuo and water (1 ml)
was added to give 55 mg (62%) of 2a, m.p. 181–182°C; [α]D −29.2, c=1, CHCl3 (lit. [α]D −39.5, c=1,
1
MeCN21); H NMR δ 2.6 (m, 1H), 2.8 (m, 1H), 4.4 (m, 1H), 4.6 (dt, J=2.2, 9.0 Hz, 1H), 5.1 (dd, 9.0,
10.0 Hz, 1H), 7.7–7.9 (m, 4H); IR (KBr) 3473, 2991, 2924, 1788, 1773, 1713, 1469, 1403, 1387, 1230,
1204, 1124, 1089, 1033, 1015, 1007, 895, 798, 717, 531 cm−1
.
4.3.6. (S)-N-Phthaloyl-α-amino-γ-butyrolactam 2b
L-2,4-Diaminobutyric acid dihydrochloride (195 mg, 1.02 mmol) and HMDS (4 ml) were refluxed in
acetonitrile (5 ml) for 72 h.22 The solvents were evaporated and the residue was dissolved in CHCl3.
After filtration the clear solution was evaporated to give 89 mg of crystalline α-amino-γ-butyrolactam
(yield 88%).
To the lactam (39 mg, 0.39 mmol) in DMF (0.5 ml) N-carboethoxyphthalimide (85 mg, 0.39 mmol)
was added and the solution was stirred for 4 h at room temperature. Half of solvent was evaporated and
water (1 ml) was added to give 61 mg (68%) of 2b, m.p. 192–194°C; [α]D −56.2, c=0.445, CHCl3; 1H
NMR δ 2.56 (m, 2H), 3.5 (q, J=7.9, 9.3 Hz, 1H), 3.6 (t, J=7.9 Hz, 1H), 4.95 (t, J=9.9 Hz, 1H), 6.9 (s, 1H),
7.7–7.9 (m, 4H); IR (KBr) 3431, 3353, 2929, 1773, 1704, 1466, 1425, 1395, 1292, 1265, 1192, 1135,
1044, 1027, 898, 802, 722, 640, 562, 525 cm−1
.
Racemic form of the compound 2b was reported.23
4.3.7. (S)-N-Phthaloyl-α-amino-γ-butyrothiolactone 2c
N-Phthaloyl-L-methionine21,24 (72 mg, 0.48 mmol) was dissolved in CH2Cl2 (3 ml) and SOCl2 (3
ml) was added. After 2 h of refluxing, the solution was evaporated to dryness. Crude acid chloride was
dissolved in CS2 (10 ml) and after addition of 3 equivalents SnCl4 in CS2 (10 ml) the solution was
refluxed with stirring for 4 h.25 Afterwards ice (0.5 g) and 2N HCl (4 ml) were added to the solution. The
product was extracted with benzene and purified by column chromatography; 2c was obtained as an oil,
yield 48 mg (40%); [α]D −56, c=1, CHCl3 (lit. [α]D −4.5, c=0.85, CHCl326); 1H NMR δ 2.6 (m, 1H),
2.9 (m, 1H), 3.5 (m, 2H), 5.0 (dd, J=7.2, 13.0 Hz, 1H), 7.76–7.87 (m, 4H); IR (KBr) 3040, 2900, 1720,
1680, 1380, 1100, 710 cm−1
.